Coppell

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Chronic kidney disease1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Alnylam Pharmaceuticals2 trials

Closed trials

• Completed

  Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

  NCT06272487· Phase 2· Alnylam Pharmaceuticals· Source

• Completed

  Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

  NCT05103332· Phase 2· Alnylam Pharmaceuticals· Source